Valtecne S.p.A. (IT:VLT) has released an update.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Valtecne S.p.A. has reported a revenue of €24 million for the first nine months of 2024, marking a 0.5% increase from the previous year. The company’s medical business line has grown by 18%, now accounting for nearly 70% of total revenues, reflecting a strategic focus on the burgeoning medical sector.
For further insights into IT:VLT stock, check out TipRanks’ Stock Analysis page.